The COVID-19 pandemic has accelerated the implementation of artificial intelligence (AI) in the global healthcare sector. Showing immense potential in a variety of fields, such as medical imaging, chronic illness management, precision medication, population health, and pharma market research, AI can serve as a tool to help improve care delivery efficiency, reduce administrative burdens, and speed up diagnostic procedures. The outcomes, so far, have shown that AI can play a vital role in identifying innovative therapies and vaccinations, and providing society with a hedge against potential healthcare crises. Continuing on the subject, in this article, we take a look at how AI is transforming the pharmaceutical industry in a post-pandemic world.
As social distance and quarantine measures remain in place in most places, every organization is looking for new effective ways to operate and meet the needs and expectations of their customers as well as employees. By offering the capabilities to facilitate distant communication, preserve food security, and enable telemedicine, AI and machine learning (ML) technologies are playing a key role in supporting that change. For government and healthcare organizations, this includes deploying AI-enabled chatbots for contactless COVID-19 symptom assessment and answering public inquiries about everything related to risk assessment without putting an additional load on the healthcare resources. It has aided in the decentralization of the distribution of accurate, validated data.
AI is also assisting academics and practitioners in analyzing massive amounts of data to estimate COVID-19’s spread in order to serve as an early warning system for future pandemics and identify vulnerable groups. BlueDot, a Canadian start-up, uses AI to detect disease outbreaks, which in fact, was one of the first to raise the alarm about a worrying respiratory infection in Wuhan, China, which in no time spiraled into a pandemic. BlueDot employs artificial intelligence to identify illness outbreaks. It sifts through news content in 65 languages, as well as airline data and animal disease networks, using machine learning algorithms to discover potential outbreaks and predict disease spread. Epidemiologists then examine the findings to ensure that the conclusions are scientifically sound.
AI is being widely used in pharma market research such as in the drug research process, to help identify the most appropriate compositions for possible pharmaceutical products, by conducting simulation testing faster than humans and identifying new potentially life-saving therapies. Google DeepMind, for instance, recently launched AlphaFold, a deep-learning system that predicts the structure of a number of understudied proteins, including those linked to COVID-19, which has made predictions of under-studied proteins that require time-consuming template modeling. Researchers are using these protein structures to investigate virus functions and improve the hypothesis generation system for future laboratory work. According to the AI drug discovery industry report by The Business Research Company, AI can improve the success rate of product development by up to 20 percent.
As the COVID-19 pandemic shows no signs of going away, healthcare industry leaders are increasingly turning to AI to refine and optimize their processes and come up with innovative medical technology solutions through life sciences market research. Collaborations between healthcare experts and AI models can be used to estimate contagion rates, forecast medical supply needs, investigate potential cures or treatments, and even identify innovative diagnosis methods through life science research. If you are a healthcare business, it goes without saying you could use all the insights as you could get about your domain to stay ahead of the competition. That’s when you need a healthcare market research specialist such as Unimrkt Healthcare. To learn more about how we cap position your business on a path of relentless success, reach out to us for a free no-obligation consultation. Simply call +91-124-424-5210 or +91-9870-377-557, or write to us at email@example.com. You can also fill out our contact form and we’ll take it from there.
Customer Service, We Make it Better
Please, fill in the form to get in touch!